Lipoteichoic acid in streptomyces hygroscopicus: Structural model and immunomodulatory activities

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Cot, Marlène ^a,b   Ray, Aurélie ^a,b   Gilleron, Martine ^a,b   Vercellone, Alain ^a,b   Larrouy Maumus, Gérald ^a,b   Armau, Elise ^c   Gauthier, Sophie ^c   Tiraby, Gérard ^c   Puzo, Germain ^a,b   Nigou, Jérôme ^a,b  

^a INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

^c Zone industrielle de Montaudran   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; GLYCEROPHOSPHATE; INTERLEUKIN 6; LIPOTEICHOIC ACID; POLYGLYCEROPHOSPHATE; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 6; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYTOKINE; IMMUNOLOGIC FACTOR; LIPOPOLYSACCHARIDE; TEICHOIC ACID; TLR2 PROTEIN, HUMAN;

ARTICLE; BACTERIAL GROWTH; CONTROLLED STUDY; CYTOKINE PRODUCTION; FATTY ACID ANALYSIS; FATTY ACID SYNTHESIS; IMMUNOMODULATION; IMMUNOSTIMULATION; INNATE IMMUNITY; MACROPHAGE; MASS SPECTROMETRY; MOLECULAR RECOGNITION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; RESIDUE ANALYSIS; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE; STAPHYLOCOCCUS AUREUS; STREPTOMYCES HYGROSCOPICUS; STRUCTURE ACTIVITY RELATION; BIOSYNTHESIS; CELL STRAIN HEK293; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; STREPTOMYCES;

ACTINOBACTERIA; POSIBACTERIA; STAPHYLOCOCCUS AUREUS; STREPTOMYCES; STREPTOMYCES HYGROSCOPICUS; STREPTOMYCES HYGROSCOPICUS SUBSP. HYGROSCOPICUS;

CYTOKINES; HEK293 CELLS; HUMANS; IMMUNOLOGIC FACTORS; LIPOPOLYSACCHARIDES; MODELS, MOLECULAR; SIGNAL TRANSDUCTION; STREPTOMYCES; STRUCTURE-ACTIVITY RELATIONSHIP; TEICHOIC ACIDS; TOLL-LIKE RECEPTOR 2;

EID: 80054771977     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026316     Document Type: Article

References (48)

1. Rahman O, Pfitzenmaier M, Pester O, Morath S, Cummings SP, et al. (2009) Macroamphiphilic components of thermophilic Actinomycetes: identification of lipoteichoic acid in Thermobifida fusca. J Bacteriol 191: 152-160.
2. Rahman O, Dover LG, Sutcliffe IC, (2009) Lipoteichoic acid biosynthesis: two steps forwards, one step sideways? Trends Microbiol 17: 219-225.
3. Fischer W, (1994) Lipoteichoic acids and lipoglycans. In: Ghuysen J-M, Hakenbeck R, editors. Bacterial cell wall Amsterdam, The Netherlands. Elsevier Science B.V pp. 199-215.
4. Brennan PJ, (2003) Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis. Tuberculosis 83: 91-97.
5. Weidenmaier C, Peschel A, (2008) Teichoic acids and related cell-wall glycopolymers in Gram-positive physiology and host interactions. Nat Rev Microbiol 6: 276-287.
6. Sutcliffe IC, Shaw N, (1991) Atypical lipoteichoic acids of gram-positive bacteria. J Bacteriol 173: 7065-7069.
7. Sutcliffe IC, (1994) The lipoteichoic acids and lipoglycans of Gram-positive Bacteria: A chemotaxonomic perspective. Systematic and Applied Microbiology 17: 467-480.
8. Sutcliffe IC, (1995) Identification of a lipoarabinomannan-like lipoglycan in Corynebacterium matruchotii. Arch Oral Biol 40: 1119-1124.
9. Gibson KJ, Gilleron M, Constant P, Sichi B, Puzo G, et al. (2005) A lipomannan variant with strong TLR-2-dependent pro-inflammatory activity in Saccharothrix aerocolonigenes. J Biol Chem 280: 28347-28356.
10. Whale GA, Sutcliffe IC, Morrisson AR, Pretswell EL, Emmison N, (2004) Purification and characterisation of lipoglycan macroamphiphiles from Propionibacterium acnes. Antonie Van Leeuwenhoek 86: 77-85.
11. Garton NJ, Gilleron M, Brando T, Dan HH, Giguere S, et al. (2002) A novel lipoarabinomannan from the equine pathogen Rhodococcus equi. Structure and effect on macrophage cytokine production. J Biol Chem 277: 31722-31733.
12. Nigou J, Gilleron M, Puzo G, (2003) Lipoarabinomannans: from structure to biosynthesis. Biochimie 85: 153-166.
13. Gnilozub VA, Streshinskaia GM, Evtushenko LI, Shashkov AS, Naumova IB, (1994) Lipoteichoic acids of Agromyces species. Mikrobiologiya 63: 275-279.
14. Potekhina NV, Streshinskaia GM, Novitskaia GV, Naumova IB, (1983) [Isolation of lipoteichoic acid from Streptomyces levoris]. Mikrobiologiia 52: 434-437.
15. Rahman O, Cummings SP, Sutcliffe IC, (2009) Phenotypic variation in Streptomyces sp. DSM 40537, a lipoteichoic acid producing Actinomycete. Lett Appl Microbiol 48: 226-229.
16. Seo HS, Cartee RT, Pritchard DG, Nahm MH, (2008) A new model of pneumococcal lipoteichoic acid structure resolves biochemical, biosynthetic, and serologic inconsistencies of the current model. J Bacteriol 190: 2379-2387.
17. Fedtke I, Mader D, Kohler T, Moll H, Nicholson G, et al. (2007) A Staphylococcus aureus ypfP mutant with strongly reduced lipoteichoic acid (LTA) content: LTA governs bacterial surface properties and autolysin activity. Mol Microbiol 65: 1078-1091.
18. Grundling A, Schneewind O, (2007) Synthesis of glycerol phosphate lipoteichoic acid in Staphylococcus aureus. Proc Natl Acad Sci U S A 104: 8478-8483.
19. Doran KS, Engelson EJ, Khosravi A, Maisey HC, Fedtke I, et al. (2005) Blood-brain barrier invasion by group B Streptococcus depends upon proper cell-surface anchoring of lipoteichoic acid. J Clin Invest 115: 2499-2507.
20. Ginsburg I, (2002) Role of lipoteichoic acid in infection and inflammation. Lancet Infect Dis 2: 171-179.
21. Seo HS, Michalek SM, Nahm MH, (2008) Lipoteichoic acid is important in innate immune responses to gram-positive bacteria. Infect Immun 76: 206-213.
22. Hashimoto M, Tawaratsumida K, Kariya H, Kiyohara A, Suda Y, et al. (2006) Not lipoteichoic acid but lipoproteins appear to be the dominant immunobiologically active compounds in Staphylococcus aureus. J Immunol 177: 3162-3169.
23. Zahringer U, Lindner B, Inamura S, Heine H, Alexander C, (2008) TLR2- promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity. Immunobiology 213: 205-224.
24. Morath S, Stadelmaier A, Geyer A, Schmidt RR, Hartung T, (2002) Synthetic lipoteichoic acid from Staphylococcus aureus is a potent stimulus of cytokine release. J Exp Med 195: 1635-1640.
25. Bunk S, Sigel S, Metzdorf D, Sharif O, Triantafilou K, et al. (2010) Internalization and coreceptor expression are critical for TLR2-mediated recognition of lipoteichoic acid in human peripheral blood. J Immunol 185: 3708-3717.
26. Fischer W, Koch HU, Haas R, (1983) Improved preparation of lipoteichoic acids. Eur J Biochem 133: 523-530.
27. Morath S, Geyer A, Hartung T, (2001) Structure-function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus. J Exp Med 193: 393-397.
28. Shashkov AS, Kosmachevskaya LN, Streshinskaya GM, Evtushenko LI, Bueva OV, et al. (2002) A polymer with a backbone of 3-deoxy-D-glycero-D-galacto-non-2-ulopyranosonic acid, a teichuronic acid, and a beta-glucosylated ribitol teichoic acid in the cell wall of plant pathogenic Streptomyces sp. VKM Ac-2124. Eur J Biochem 269: 6020-6025.
29. Shashkov AS, Tul'skaya EM, Evtushenko LI, Denisenko VA, Ivanyuk VG, et al. (2002) Cell wall anionic polymers of Streptomyces sp. MB-8, the causative agent of potato scab. Carbohydr Res 337: 2255-2261.
30. Hoischen C, Gura K, Luge C, Gumpert J, (1997) Lipid and fatty acid composition of cytoplasmic membranes from Streptomyces hygroscopicus and its stable protoplast-type L form. J Bacteriol 179: 3430-3436.
31. Siri N, Lacroix M, Garrigues JC, Poinsot V, Couderc F, (2006) HPLC-fluorescence detection and MEKC-LIF detection for the study of amino acids and catecholamines labelled with naphthalene-2,3-dicarboxyaldehyde. Electrophoresis 27: 4446-4455.
32. Morelle W, Michalski JC, (2007) Analysis of protein glycosylation by mass spectrometry. Nat Protoc 2: 1585-1602.
33. Shashkov AS, Streshinskaya GM, Senchenkova SN, Kozlova YI, Alferova IV, et al. (2006) Cell wall teichoic acids of streptomycetes of the phenetic cluster 'Streptomyces fulvissimus'. Carbohydr Res 341: 796-802.
34. Tul'skaia EM, Shashkov AS, Evtushenko LI, Bueva OV, Naumova IB, (1997) Strutural Identity of teichoic acids from Actinomycete species Strepotomyces hygroscopicus. Biochemistry (Mosc) 62: 289-293.
35. Deininger S, Stadelmaier A, von Aulock S, Morath S, Schmidt RR, et al. (2003) Definition of structural prerequisites for lipoteichoic acid-inducible cytokine induction by synthetic derivatives. J Immunol 170: 4134-4138.
36. Lehner MD, Morath S, Michelsen KS, Schumann RR, Hartung T, (2001) Induction of cross-tolerance by lipopolysaccharide and highly purified lipoteichoic acid via different Toll-like receptors independent of paracrine mediators. J Immunol 166: 5161-5167.
37. Han SH, Kim JH, Martin M, Michalek SM, Nahm MH, (2003) Pneumococcal lipoteichoic acid (LTA) is not as potent as staphylococcal LTA in stimulating Toll-like receptor 2. Infect Immun 71: 5541-5548.
38. Triantafilou M, Manukyan M, Mackie A, Morath S, Hartung T, et al. (2004) Lipoteichoic acid and toll-like receptor 2 internalization and targeting to the Golgi are lipid raft-dependent. J Biol Chem 279: 40882-40889.
39. Kang JY, Nan X, Jin MS, Youn SJ, Ryu YH, et al. (2009) Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer. Immunity 31: 873-884.
40. Seo HS, Nahm MH, (2009) Lipoprotein lipase and hydrofluoric acid deactivate both bacterial lipoproteins and lipoteichoic acids, but platelet-activating factor-acetylhydrolase degrades only lipoteichoic acids. Clin Vaccine Immunol 16: 1187-1195.
41. Fischer W, (1988) Physiology of lipoteichoic acids in bacteria. Adv Microb Physiol 29: 233-302.
42. Fischer W, (1993) Molecular analysis of lipid macroamphiphiles by hydrophobic interaction chromatography, exemplified with lipoteichoic acids. Anal Biochem 208: 49-56.
43. Draing C, Sigel S, Deininger S, Traub S, Munke R, et al. (2008) Cytokine induction by Gram-positive bacteria. Immunobiology 213: 285-296.
44. Hashimoto M, Furuyashiki M, Kaseya R, Fukada Y, Akimaru M, et al. (2007) Evidence of immunostimulating lipoprotein existing in the natural lipoteichoic acid fraction. Infect Immun 75: 1926-1932.
45. Tapping RI, Akashi S, Miyake K, Godowski PJ, Tobias PS, (2000) Toll-like receptor 4, but not toll-like receptor 2, is a signaling receptor for Escherichia and Salmonella lipopolysaccharides. J Immunol 165: 5780-5787.
46. Gilleron M, Bala L, Brando T, Vercellone A, Puzo G, (2000) Mycobacterium tuberculosis H37Rv parietal and cellular lipoarabinomannans. Characterization of the acyl- and glyco-forms. J Biol Chem 275: 677-684.
47. Gilleron M, Garton NJ, Nigou J, Brando T, Puzo G, et al. (2005) Characterization of a truncated lipoarabinomannan from the Actinomycete Turicella otitidis. J Bacteriol 187: 854-861.
48. Chen FT, Dobashi TS, Evangelista RA, (1998) Quantitative analysis of sugar constituents of glycoproteins by capillary electrophoresis. Glycobiology 8: 1045-1052.